INTRODUCTION
Cells of the mammalian kidney medulla are physiologically subjected to dramatically elevated levels of NaCl and urea by virtue of the renal-concentrating mechanism. Signalling events initiated by urea in medullary cells bear hallmarks of both the stress response and signalling through receptor tyrosine kinases. Urea increases transcription and expression of the stressresponsive transcription factors, Egr-1 and Gadd153, and the stress-responsive enzyme, haem oxygenase-1, in part via an oxidative stress-dependent mechanism [1, 2] . Urea signalling also resembles peptide mitogen signalling in that multiple receptor tyrosine kinase effector pathways are activated by urea in renal medullary cells, including (i) the Shc\Grb2\Son-of-Sevenless (SOS)\Ras\Raf\mitogen-activated protein kinase (MAPK)\ extracellular signal-regulated kinase (ERK) kinase (' MEK ')\ ERK\Elk-1 pathway [3] [4] [5] [6] , (ii) phospholipase C-γ\Ins(1,4,5)P $ [3] and (iii) phosphoinositide 3-kinase\Akt\p70 S6 kinase [6] . In some models, urea has also been implicated in promoting proliferation of renal epithelial cells [7, 8] . In addition, much like a peptide mitogen, urea appears to protect from the effect of hypertonic stress in renal medullary cells, both at the level of tonicity-dependent transcription [9] and at the level of apoptosis [10] .
Urea signalling is sensitive, in part, to the thiol-containing antioxidant, N-acetyl--cysteine [1, 2] , which has been shown to inhibit ligand-dependent and -independent activation of the epidermal growth factor (EGF) receptor (EGFR) [11, 12] . Accumulating data from many laboratories indicate that the EGFR may be activated in trans and thereby serve as an important signalling intermediate following activation of G-protein-coupled receptors (reviewed in [13] ) and exposure to environmental stressors [11, 12, 14, 15] . Severe hypertonic stress in non-renal cells resulted in clustering and activation of a variety of receptors including the EGFR [16, 17] . Although some groups concluded that this was a ligand-independent process brought about by stress-induced inhibition of tyrosine phosphatase activity [12] , subsequent studies have emphasized an unexpected liganddependent process (see below).
The EGFR tyrosine kinase family includes four members, erbB1-erbB4 ; erbB1 is the ' classical ' EGFR. Multiple ligands interact with erbB1 : EGF, transforming growth factor-α, amphiregulin, betacellulin, epiregulin and heparin-binding EGF (HB-EGF). All activate the EGFR family via ectodomain shedding wherein enzymic cleavage of an extracellular domain by a metalloproteinase liberates the soluble peptide agonist. In the case of the best-studied ligand, HB-EGF, multiple signalling cascades, including those initiated by activation of a wide range of G-protein-coupled receptors, utilize this so-called triplemembrane passing signal [13] of transactivation through the EGFR. Relevance of this pathway to solute signalling is also provided by recent data from Sheikh-Hamad and colleagues who detected co-localization of two osmotically responsive [18, 19] cell-surface markers with HB-EGF in renal epithelial cells [20] .
One of these markers, CD9, had been shown to potentiate the effect of HB-EGF in other systems [21] . We therefore investigated the role of EGFR transactivation and HB-EGF signalling in renal medullary cell signalling response to physiological levels of urea.
EXPERIMENTAL
Cell culture conditions and reagents mIMCD3 (murine inner medullary collecting duct) cells were maintained and passaged as described previously [22] . Supplemental solute was applied at $ 200 mOsm (200 mM urea versus 100 mM NaCl). All reagents were purchased from Sigma unless otherwise specified. Pharmacological inhibitors and agonists were used as follows : AG1295 (100 nM-1 µM ; Calbiochem), AG1478 (100 nM ; Calbiochem), EGF (100 nM), HB-EGF (100 ng\ml), ilomastat (50 µM ; Calbiochem), PD153035 (100 nM), CGS27023A [matrix metalloproteinase (MMP)-3 inhibitor-II ; 10-30 µM ; Calbiochem], doxycycline (100 µM), actinonin (10 µM), lysophosphatidic acid (10 µM), pertussis toxin (100 ng\ml) and CRM197 (10 µg\ml). Inhibitors were applied 30 min prior to solute or ligand treatment unless otherwise indicated ; all inhibitors were present for the duration of the solute or ligand treatment interval (additional 5 min-6 h, depending upon assay). Ilomastat required a DMSO vehicle control at 0.5-2.0 % (v\v) DMSO, which influenced basal cell function under some conditions (see the Results section and Figure legends) . Egr-1-Luc (also known as 632-Luc [23] ) and BGT-2X-Luc [6] plasmids have been described ; the Elk-1\GAL4 chimaeric expression plasmid and 5XGAL4-Luc reporter [24, 25] were kindly provided by R. Maurer (Oregon Health & Science University, Portland, OR, U.S.A.).
Biochemical and molecular biological assays
Immunoblot analysis was performed as described previously [4, 22] using the following primary antibodies : anti-phospho (p)-ERK, anti-p-Jun N-terminal kinase (JNK) and anti-p-p38 (all from Cell Signalling Technology) ; anti-Gadd153, anti-pY99 (anti-phosphotyrosine) and anti-Egr-1 (all from Santa Cruz Biotechnology) ; and anti-p-(1068)-EGFR (Cell Signalling Technologies). Shc phosphorylation was assessed via anti-Shc immunoprecipitation (primary antibody from Upstate Biotechnology) from detergent lysates, followed by SDS\PAGE and immunoblotting with anti-pY99 antibody [6] . Transienttransfection and reporter-gene analyses were performed as described previously [23] using Egr-1-Luc (also known as 632-Luc [23] ), a luciferase reporter plasmid (pXP2 [26] ) driven by 1.2 kb of the murine Egr-1 5h-flanking sequence [27] and normalized to a co-transfected β-galactosidase gene under the control of a viral (cytomegalovirus) long-terminal-repeat constitutively active promoter. Caspase-3 assay was performed as described previously [10] .
For RNase protection assay, partial murine Egr-1 cDNA was reverse-transcribed from murine kidney poly(A) + RNA [9] using primers 5h-CCA ATC CCA GCT CAT CAA AC-3h and 5h-TCT TGC GTT CAT CAC TCC TG-3h. The product was gel-purified and TA-subcloned into pCR4 (Invitrogen). Resultant plasmid pCR4-Egr-1(1221-1525) was linearized with SpeI and primed from T7 to generate a biotinylated Egr-1 riboprobe as described previously [9] . RNase protection assay was then performed as described previously [9] .
Depicted data are meanspS.E.M. from at least three separate experiments unless otherwise indicated. For immunoblot data, a representative figure is shown. Statistical significance was ascribed to P 0.05 via t test (VassarStats ; http:\\vassun. vassar.edu\"lowry\VassarStats.html).
RESULTS

Urea induces EGFR phosphorylation
We investigated the ability of urea to activate the EGFR in cultured cells derived from the murine renal medulla. Urea (200 mM) at 1 and 5 min of treatment resulted in phosphorylation of Tyr-1068 in the EGFR, as did treatment with the positive control, EGF, as determined via anti-phospho-Y1068-specific immunoblotting ( Figure 1A) . Pretreatment with the specific tyrphostin-based EGFR kinase inhibitor, AG1478, substantially blocked both the urea-and EGF-associated increment in EGF phosphorylation at this tyrosine residue ( Figure 1B) , underscoring the utility of this compound in the present model as an inhibitor of EGFR function.
Urea-inducible immediate-early gene transcription is EGFRdependent
Because we showed previously that urea enhanced the transcription and expression of Egr-1, the ability of EGFR kinase inhibition to block this phenomenon was investigated. The proximal 1.2 kb of the murine Egr-1 5h-flanking sequence, subcloned upstream of a luciferase reporter gene [23] , was initially used to address this question. AG1478 or vehicle control had no effect upon basal levels of Egr-1 transcription (Figure 2A ). Urea increased transcription $ 6-fold, consistent with earlier observations [23] , and this effect was almost completely inhibited by AG1478 (Figure 2A ). The highly potent inhibitor of the EGFR kinase, PD153035, also known as compound 32, similarly blocked urea-dependent signalling to Egr-1 transcription (results not shown). As we showed previously [23] , hypertonic NaCl (in contrast to urea) failed to up-regulate Egr-1-Luc reporter gene activity (results not shown).
As an additional control, the effect of AG1478 upon expression of a luciferase reporter gene driven by the tonicity-responsive enhancer element (TonE) [28] was examined in parallel. As anticipated, hypertonic NaCl (100 mM ; osmotically approximately equivalent to 200 mM urea) increased TonE-dependent reporter gene activity ; AG1478, however, failed to influence this phenomenon ( Figure 2B ), indicating that the inhibitory effect of AG1478 is specific to urea signalling and cannot be generalized to all hyperosmotic phenomena. Urea, in the presence or absence of AG1478, exerted no effect upon this tonicity-responsive promoter (results not shown).
To further investigate the EGFR dependence of the AG1478 inhibition of urea signalling, the effect of a structurally related tyrphostin compound exhibiting specificity towards the plateletderived growth factor receptor (PDGFR) kinase, but not the EGFR kinase, was also examined. In these experiments, cells were treated with either urea or EGF (100 nM), in the presence or absence of each kinase inhibitor. AG1295 failed to influence either urea-or EGF-dependent Egr-1-Luc reporter gene activity ( Figure 2C ). AG1478 abrogated the effect of urea and, as
Figure 3 EGFR kinase inhibition blocks urea-inducible Egr-1 protein and mRNA expression
Cells (mIMCD3), in the presence (jAG1478) or absence (kAG1478) of AG1478, were treated with urea (200 mM), EGF (100 nM) or HB-EGF (100 ng/ml) for 1 h and whole-cell lysates were subjected to anti-Egr-1 immunoblotting (A). *Denotes P 0.05 relative to kAG1478 for the same condition. (B) Anti-Egr-1 immunoblot depicting the effect of pretreatment with the EGFRspecific inhibitor AG1478 or the PDGFR-specific inhibitor AG1295, upon Egr-1 protein abundance following 1 h of control (C) or urea (U) treatment. (C) RNase protection assay of Egr-1 mRNA abundance in response to control treatment (C) or treatment with urea (U) or either of the EGFR ligands, EGF (E) or HB-EGF (H), in the presence or absence of the EGFR inhibitor, AG1478. Egr-1 and actin riboprobes were run in the last lane and are designated P Egr-1 and P actin , respectively. Protected fragments are indicated by the filled arrowheads. A non-specific band (NS ; open arrowhead) migrated more slowly than the specifically protected Egr-1 probe.
expected, EGF. Interestingly, AG1478 was less inhibitory toward EGF-dependent than urea-dependent Egr-1 transcription. Of note, an additional EGFR ligand, HB-EGF was also examined ; the effect of HB-EGF was indistinguishable from that of EGF with respect to Egr-1-Luc reporter gene activity (results not shown). Both EGFR ligands, however, were slightly less potent than urea ($ 20 % less effective at saturating concentrations ; Figure 2C and results not shown).
The effect of inhibition of EGFR signalling on expression of Egr-1 at the protein level was examined as a correlate of reporter gene activity. By immunoblot analysis of whole-cell lysates, urea and the two EGFR ligands, EGF and HB-EGF, increased Egr-1 protein abundance to an equivalent degree ( Figure 3A ). AG1478 partially (and equivalently) blocked Egr-1 protein upregulation by all stimuli, and suppressed basal levels as well ( Figure 3A) . The PDGFR-directed kinase inhibitor, AG1295, failed to block urea-dependent Egr-1 expression (Figure 3B ),
Figure 4 Inhibition of EGFR kinase signalling blocks urea-inducible Elk-1-activation
Cells were transfected with expression plasmids encoding chimaeric Elk-1/GAL4 transcription factor and a luciferase reporter gene driven by five tandem repeats of the yeast GAL4 enhancer element. Reporter gene activity was assessed after 6 h of control or urea treatment, in the presence or absence of the indicated inhibitors of EGFR kinase activity.
Figure 5 AG1478 partially blocks the effect of urea upon ERK activation
Cells were pretreated for 30 min with vehicle or AG1478 (100 nM), prior to treatment for the indicated interval with urea (200 mM) or NaCl (200 mOsm). Cell lysates were subjected to immunoblotting with anti-pERK. AG1478 had almost completely blocked the effect of urea and of hypertonicity by 30 min of treatment whereas it had a more modest effect at 5 min.
consistent with its lack of effect upon Egr-1 transcription. There was a suggestion on some autoradiograms that, in addition to abundance, Egr-1 mobility was increased in response to urea treatment although the significance of this observation remains unclear. Because the fold-induction of Egr-1 protein expression appeared to be less than might be suggested by the reporter gene data and because of the dissimilar relative effects of urea and EGF in the reporter gene and immunoblot analyses, quantification of Egr-1 mRNA abundance was sought using RNase protection assay ( Figure 3C ). Urea and the two EGFR ligands, EGF and HB-EGF, increased Egr-1 mRNA abundance to an equivalent degree. All were highly sensitive to pretreatment with AG1478, consistent with the Egr-1 immunoblot data.
Urea signalling to ERK and Elk-1 is EGFR-dependent
Because Elk-1-dependent transactivation of composite serumresponse elements (SREs ; see Figure 2A ) underlies urea-inducible Egr-1 transcription [23] , the effect of EGFR kinase inhibition upon urea signalling was tested using a reporter gene system reflecting activation of Elk-1 [24, 25] . Cells were transfected with an expression plasmid encoding the activation domain of Elk-1 fused to the DNA-binding domain of the yeast transcription Figure 6 Inhibition of EGFR kinase signalling blocks urea-inducible protection from hypertonic apoptosis Cells were exposed to hypertonic stress (200 mOsm NaCl) for 6 h, in the presence or absence of pretreatment with urea and/or the EGFR kinase inhibitor, PD153035 (100 nM), and then assayed for activity of the apoptotic protease, caspase-3, via in vitro cleavage of a fluorigenic caspase-3 substrate peptide. PD153035 pretreatment abolished the protective effect of urea. *Denotes P 0.05 relative to jNaCl/kurea.
factor, GAL4 ; simultaneously, cells were also transfected with a reporter plasmid encoding luciferase under the control of tandem repeats of the GAL4 DNA consensus sequence. Consistent with earlier data [3] , urea treatment increased Elk-1 activity (Figure 4) . AG1478 blocked the effect of urea, consistent with a role for the EGFR kinase in this process. An additional potent inhibitor of the EGFR kinase, PD153035, also blocked ureainducible Elk-1 activation (Figure 4) . Hypertonic stress (100 mM NaCl for 6 h) only modestly increased GAL4-driven reporter gene activity in this model ($ 40 % ; n l 2 ; results not shown), although it was sensitive to AG1478.
Because Elk-1 is activated by ERK, and because ERK has been implicated in urea signalling [4] , the effect of EGFR kinase inhibition upon ERK activation was examined. As anticipated, urea increased activation of both ERK1 and ERK2, as assessed via anti-pERK immunoblotting ; this effect was most evident after 5 min of treatment ( Figure 5 ). AG1478 pretreatment modestly inhibited the 5 min effect and almost completely blocked the 30 min effect of urea. Hypertonic stress also activated ERK, although to a lesser degree and with different kinetics (30 min effect 5 min effect), consistent with our earlier data [3, 4] . Similar to the case for urea, AG1478 was a much more effective inhibitor at the 30 min than the 5 min time point.
Urea-inducible cytoprotection from hypertonic stress is EGFRdependent
Because urea affords cytoprotection from the pro-apoptotic effect of hypertonic NaCl [10] and because peptide mitogens may similarly protect from hypertonicity [29] , we investigated whether urea-dependent activation of the EGFR kinase was required for cytoprotection by urea. Pretreatment with urea afforded modest (40 %) protection from hypertonicity-inducible activation of caspase-3 [10] , a late component of the apoptotic programme ( Figure 6 ). Pretreatment with the potent EGFR kinase inhibitor PD153035 completely blocked this cytoprotective effect of urea.
Figure 7 Metalloproteinase inhibitors block urea signalling
Cells (mIMCD3) transfected with Egr-1-Luc, as in Figure 2 (A), were pretreated with ilomastat (50 µM for 30 min), or with the metalloproteinase inhibitor CGS27023A (30 µM), for 30 min prior to control or urea treatment for 6 h (A). In (B), the effects of the non-specific metalloproteinase inhibitors doxycycline (100 µM) and actinonin (10 µM) upon urea-and EGF-dependent Egr-1-luciferase reporter gene activity were examined ; these effects were compared with vehicle alone. *Denotes P 0.05 relative to vehicle treatment for the same condition.
Metalloproteinase activation in urea signalling
Because metalloproteinase activation has recently been implicated in EGFR ligand processing, the requirement for metalloproteinase action in urea signalling was investigated. Similar to the effect seen with AG1478, the metalloproteinase inhibitor, ilomastat, completely blocked the effect of urea upon Egr-1 reporter gene activity, whereas vehicle produced no effect (Figure 7A) . [Ilomastat is poorly soluble, requiring a $ 2 % (v\v) DMSO vehicle.] Because the metalloproteinase MMP-3 has been specifically implicated in HB-EGF ectodomain cleavage [30] , the MMP-3 inhibitor CGS27023A [also known as N-isobutyl-N-(4-methoxyphenylsulphonyl)-glycylhydroxamic acid] was also examined in this context. Although less potent than ilomastat in other experimental contexts, CGS27023A substantially blocked urea signalling to Egr-1 reporter gene activation ( Figure 7A ). Two other inhibitors of metalloproteinase action, doxycycline and actinonin, also modestly blocked the urea effect, and, as expected, had no effect upon EGF-dependent Egr-1 transcription or upon basal levels of transcription ( Figure 7B ). The effect of the EGFR ligand, HB-EGF, in the presence or absence of ilomastat, was equivalent to that of EGF (results not shown).
To demonstrate specificity of metalloproteinase involvement to urea signalling (in contrast to universality to all hyperosmotic solute phenomena), control experiments were again performed using the model of hypertonic NaCl-dependent activation of a TonE-driven reporter plasmid (as in Figure 2B ). In contrast to the case for urea-inducible gene regulation, and consistent with data in Figure 2 (B), ilomastat failed to significantly influence TonE-dependent gene transcription by hypertonic NaCl (results not shown).
We next sought to establish the metalloproteinase dependence of another EGFR-mediated urea-inducible signalling event.
Ilomastat blocked the urea-and tonicity-dependent late phase (i.e. 30 min 5 min) of ERK activation (Figure 8) , analogous to the effect of AG1478 ( Figure 5) . Although urea has a more modest effect upon the other MAPKs, JNK and p38 [4, 31, 32] , hypertonic NaCl is known to activate these kinases. Because metalloproteinase inhibition blocked hypertonic activation of ERK, its effect upon JNK and p38 activation was examined. As expected, urea only minimally activated JNK and p38 as determined by anti-pMAPK immunoblotting, and this effect was insensitive to ilomastat. NaCl strongly activated both JNK and p38 at the 30 min time point, as expected, and did so in a largely metalloproteinase-independent fashion. Of note, in the antipJNK immunoblot, the prominent band migrating at $ 43 kDa probably represents cross-reactivity with pERK ; this is supported by co-migration of the band with ERK and by its appearance only under conditions wherein ERK phosphorylation is most dramatically up-regulated (i.e. 5 min of urea treatment).
The metalloproteinase dependence of EGFR tyrosine phosphorylation was also assessed as a correlate of urea signalling. Ilomastat pretreatment largely prevented urea-inducible but not EGF-inducible tyrosine (Tyr-1068) phosphorylation of EGFR ( Figure 8B ).
Urea-inducible transactivation of EGFR requires HB-EGF
Because the principal EGFR ligand and metalloproteinase substrate implicated in transactivation of the EGFR kinase is HB-EGF, a role for HB-EGF was sought in urea signalling to EGFR kinase activation. CRM197 has been used to convincingly demonstrate HB-EGF dependence (in contrast to metalloproteinase dependence). HB-EGF is the cell-surface receptor for diphtheria toxin [33] , and a non-toxic point-mutant diphtheria toxin analogue, CRM197, has been used to inhibit HB-EGF signalling [34, 35] . Although active in primate systems, CRM197-like diphtheria toxin is inactive in rodent models, such as the murine cell lines used for the present studies, because of poorly conserved amino acid sequence in the toxin-binding region of HB-EGF [34] . There are no primate models in which urea signalling has been demonstrated, owing to the dearth of adequately differentiated human kidney epithelial cell lines. We compared sequences of full-length HB-EGF among various species and noted relatively greater homology between the porcine and primate cDNAs (results not shown). Furthermore, Figure 9 CRM197 blocks urea signalling (A) Urea-inducible Egr-1 reporter gene activity is sensitive to EGFR inhibition by AG1478 (100 nM) and PD153035 (100 nM) in the porcine renal epithelial LLC-PK 1 cell line. Cells received control or urea (200 mM) treatment for 6 h. (B) Porcine renal epithelial LLC-PK 1 cells transiently transfected with Egr-1-Luc were pretreated with vehicle or with the non-cytotoxic derivative of diphtheria toxin, CRM197 (10 µg/ml for 30 min), prior to urea (200 mM) or EGF (100 nM) treatment for 6 h. CRM197 blocked the effect of urea but not that of EGF. *Denotes P 0.05 relative to vehicle treatment for the same condition.
Figure 8 Effect of ilomastat upon MAPK activation and EGFR phosphorylation mirrors that of AG1478
porcine and human HB-EGF were identical across the CRM197-binding region (residues 106-147 ; results not shown). It was reasoned that renal epithelial cells derived from the pig might afford a suitable model for use of this highly specific HB-EGF inhibitor. In the porcine renal epithelial cell line LLC-PK " , which exhibits urea-inducible signalling [7] , urea increased Egr-1 reporter gene activity in an AG1478-and PD153035-sensitive (i.e. EGFR-dependent) fashion ( Figure 9A ). This effect was almost completely blocked by the HB-EGF inhibitor, CRM197 ( Figure  9B ), whereas the effect of EGF was CRM197-insensitive, as expected. These data strongly suggested that urea was activating the EGFR kinase via HB-EGF.
A possible role for a G-protein-coupled receptor
Because HB-EGF-dependent signalling to transactivation of the EGFR kinase in response to ligand-dependent activation of heterotrimeric G-protein-coupled receptors (e.g. [35] ) is generally (but not universally) G o/i -dependent (i.e. pertussis toxinsensitive), we sought to determine whether urea operated through this mechanism. Pretreatment of mIMCD3 cells with pertussis toxin substantially blocked urea-inducible Egr-1 reporter gene activity (by 50p4 % ; n l 3 ; results not shown). The effect of pertussis toxin upon signalling via EGF, which signals independently of G o/i to immediate-early gene transcription, was much more modest (26p7 % ; n l 3 ; results not shown) yet still achieved statistical significance. Pertussis toxin exerted no effect upon basal Egr-1 transcription. In this model, the effect of the bona fide G-protein-coupled receptor agonist (and G o/i activator [36] ), lysophosphatidic acid, was inhibited by pertussis toxin ($ 70 % ; n l 3 ; results not shown). In contrast to its effect upon urea-inducible Egr-1 transcription, pertussis toxin (at up to 1 µg\ml) failed to influence ERK activation by urea at 5, 15 or 30 min of treatment as assessed via anti-P-ERK immunoblotting (results not shown).
DISCUSSION
In renal epithelial cells and in other models, signalling by hypertonic stress is distinct from that of urea. Hypertonic NaCl, for example, induces a protracted change in cell volume ; urea, Involvement of the epidermal growth factor receptor in urea signalling being membrane-permeant, fails to chronically affect cell volume. Hypertonic stress increases expression of a small set of adaptive gene products including osmolyte synthesis and transport proteins, principally via TonE enhancer-binding protein (TonEBP)-dependent transcriptional regulation (reviewed in [37] ). Urea fails to similarly upregulate this pathway ; in cultured cells, urea inhibits TonE enhancer-binding protein-dependent transcription [9] . In renal epithelial cells, urea activates a range of signalling events unique to this solute or exhibiting distinctive kinetics [4] [5] [6] 31, 32] . Similarly, urea increases expression of the transcription factors Egr-1 and Gadd153, whereas hypertonic stress does not to an appreciable degree [1, 22] . Because signalling by urea stress, unlike hypertonic stress, was reminiscent of a ligand-dependent, receptor-mediated phenomenon, effectors of such pathways were investigated in the urea response.
Although HB-EGF signalling has not previously been implicated in the urea response, a role in adaptation to hypertonic stress has been suggested. Nakamura et al. [38] observed that HB-EGF and CD-9 co-localize in monkey kidney cells ; SheikhHamad et al. reported that CD-9 expression is up-regulated by osmotic stress [19] and, along with another osmotically responsive protein, β1-integrin [18] , co-localizes with HB-EGF in cells of the renal medullary thick ascending limb [20] . This observation has also recently been extended to normal human renal tissue [39] . Others have shown osmotic inducibility of the HB-EGF protein, although no data were presented with respect to HB-EGF signalling in this context [40, 41] .
Prior to the elucidation of the role of HB-EGF in this process, involvement of the EGFR in signalling by hypertonicity [16, 17] and other environmental stressors [11, 12] had been demonstrated by several groups, although this phenomenon was initially attributed to down-regulated tyrosine-directed phosphatase activity [12, 42, 43] . In addition, other receptors besides the EGFR may be activated in response to severe osmotic stress [17] ; these data, however, required subjection of non-renal cells to a potentially pro-apoptotic degree of osmotic stress (i.e. 600 mM sorbitol), so their relevance to other models is less clear.
In addition to physical stressors, ligand-dependent events also transactivate the EGFR in diverse cell culture models (reviewed in [44] ) ; virtually all involve activation of G-protein-coupled receptors and many proceed through pertussis toxin-sensitive (G o/i -dependent) pathways. More recently, the involvement of HB-EGF cleavage and metalloproteinase function in this process has been documented in response to diverse agonists of G-protein-coupled receptors [35, [45] [46] [47] [48] [49] [50] . The mechanism through which this signal is transduced potentially involves Src, intracellular calcium, PYK2 or protein kinase C [47, 48] ; all but the first have previously been implicated in urea signal transduction [51] [52] [53] . The metalloproteinase mediating the effect upon HB-EGF and perhaps other EGFR ligands remains obscure. MMP-3 [30] , a disintegrin and metalloprotease 12 (ADAM12) [54] and ADAM10 [55] have all been implicated but whether any represent the physiological effector in the present context is unclear.
It has been challenging in other models to conclusively link transactivation of the EGFR kinase with biochemical evidence of ectodomain cleavage of an EGFR ligand ; most published reports have relied upon metalloproteinase inhibitor data. Even neutralizing antisera to the EGFR or its ligands are ineffective in the murine model under investigation. To explore HB-EGF involvement in a specific fashion [34, 35] , we used CRM197, a non-cytotoxic point mutant of the diphtheria toxin known to bind to and inactivate HB-EGF in cells of primate, but not rodent, origin [33, 34] . We performed these studies with CRM197 in the porcine renal epithelial cell line LLC-PK " , after establishing that porcine and human HB-EGF harbour identical diphtheria toxin-binding domains. Because CRM197 effectively blocked urea signalling in LLC-PK " cells, we concluded that HB-EGF represented the most likely candidate EGFR ligand operative in response to urea stress.
Inhibitors of both HB-EGF ectodomain cleavage and EGFR activation block ERK activation principally at later time points (i.e. 30 min) in response to both urea and hypertonic stress, and exhibit little effect at the earliest times (i.e. 5 min). This is consistent with the presence of two independent signalling events contributing to the ERK response. We suggested this possibility previously because early ERK activation in response to urea or hypertonic stress was Ras-independent whereas later ERK activation ($ 15 min) was substantially Ras-dependent [5] . Elk-1 activation in the present model also appears to be a consequence of this later phase of ERK activation because pharmacological inhibition of EGFR kinase activity completely blocked Elk-1-dependent transactivation ( Figure 4) ; this is consistent with prior observations in many systems wherein Elk-1 activation is Rasdependent (reviewed in [56] ). HB-EGF activation in response to a primary stimulus may itself be Raf\Ras\ERK-dependent [57] ; although this could account for the initial round of metalloproteinase-inhibitor-independent ERK activation, it is not consistent with the Ras-dependency data in the model of urea stress.
Although elevated concentrations of urea and NaCl signal through largely distinct mechanisms, there is some overlap. It is unclear, however, whether this overlap is functionally significant. For example, NaCl activates both ERKs and the ERK substrate and transcription factor, Elk-1, albeit to a lesser extent than urea and, in the case of ERK, with dissimilar kinetics. The modest hypertonicity-dependent activation of ERK and Elk-1 does not result in Egr-1 reporter gene activation or Egr-1 protein expression. Hypertonic stress, as a global suppressor of translation, ' superinduces ' mRNAs encoding immediate-early gene products such as Egr-1 in a fashion analogous to cycloheximide [58] . Hypertonicity modestly increases Egr-1 mRNA [59] but no functional protein product results. Urea, in contrast, increases Egr-1 transcription by both nuclear run-off and reporter gene analyses and results in production of a functional, transcriptionally competent protein product [22] . The Egr-1 reporter gene assay requires synthesis of the reporter protein and, in the case of hyperosmotic solute stress, affords a better index of functionally significant gene regulation (i.e. that which results in production of a protein product) than does quantification of mRNA abundance alone.
There are abundant cellular actions of metalloproteinases upon matrix constituents ; however, proteolytic processing of non-matrix substrates is increasingly appreciated. Potentially ilomastat-sensitive metalloproteinases may influence signalling by multiple cytokines including tumour necrosis factor-α, interleukin-1, transforming growth factor-β and vascular endothelial growth factor (reviewed in [60] ). Dependence upon the EGFR axis was evident in the present model of urea signalling because multiple highly specific inhibitors of the EGFR kinase were functionally equivalent to ilomastat. In addition, the urea response was sensitive to CRM197 which is highly specific to HB-EGF action. Furthermore, urea treatment resulted in tyrosine phosphorylation of the EGFR. Therefore, a role for both HB-EGF ectodomain cleavage and EGFR transactivation in urea signalling was established. Other urea-responsive signalling events including late activation of ERK and the adapter protein Shc, and up-regulation of the stress-responsive transcription factor, Gadd153, also appear to be downstream of this activation event.
We had previously postulated that a urea-sensing molecule in renal medullary cells would probably be a receptor tyrosine kinase, based upon the downstream signalling events activated in response to urea treatment [51] . It now appears that a significant subset of these signalling events are a consequence of activation of the EGFR kinase following metalloproteinase activation and ectodomain shedding of an EGFR agonist, including ureadependent cytoprotection from hypertonic stress. The present data also implicate in preliminary fashion a urea-sensing G-protein-coupled receptor, potentially operating through G o/i . This latter observation is of particular interest because G-proteincoupled receptors directly respond to a much broader array of stimuli (e.g. airborne odorants, divalent ion concentration and light) than do receptor tyrosine kinases, which are generally activated only by peptide mitogens. G-protein-coupled receptors, therefore, represent an attractive family of candidates for a ureasensing protein.
This study was supported by the National Institutes of Health and the Department of Veterans Affairs.
